GlaxoSmithKline Recalls Asthma Inhalers Nationwide

Comments (0)

Drug manufacturer GlaxoSmithKline recently announced that it was recalling almost 600,000 asthma inhalers from retailers, wholesalers, pharmacies and hospitals in the U.S. The company announced the recall after getting large numbers of complaints from consumers.

The inhalers have a defect which causes them to deliver a smaller dose of medicine than expected. This is caused by a leak in the propellant that delivers the medicine. Fortunately, the recall did not cause any serious health problems, and the Food and Drug Administration has approved the recall as a “Level 2” recall, which means that the product may cause temporary or medically reversible side effects.

According to GSK, the inhalers can still be beneficial for some patients, although there is a small risk to patients who need a larger dose of medication and who rely on rescue inhalers. The company says that it is committed to supplying higher quality products and regrets any inconvenience to customers.

Drug manufacturers have a responsibility to their customers to make medications that are safe for consumers. If they fail to do so and a patient is harmed, the drug company can be held legally liable for damages. If you or a loved one has been injured by a defective drug, call the Houston personal injury attorneys at Kennedy Hodges at 855-947-0707. We can help. Call today to learn more or to schedule a free consultation. 

Be the first to comment!

Post a Comment

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."


Email:* (will not be published)


Notify me of follow-up comments via email.